| P50 | author | Alexander Claviez | Q38545732 |
| P2093 | author name string | H Kreipe | |
| | J Peters | |
| | M Tiemann | |
| | R Schneppenheim | |
| | R Parwaresch | |
| P2860 | cites work | Distribution and phenotype of Epstein-Barr virus-harboring cells in Hodgkin's disease | Q45878625 |
| | Treatment of children with Hodgkin's disease--results of the German Pediatric Oncology Group | Q46817021 |
| | Topographical dissociation of BCL-2 messenger RNA and protein expression in human lymphoid tissues. | Q52517242 |
| | EBV infection patterns in Hodgkin's disease and normal lymphoid tissue: expression and cellular localization of EBV gene products | Q53024631 |
| | Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization. | Q53038037 |
| | An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. | Q53541156 |
| | The t(14;18) translocation in Hodgkin's disease | Q67581023 |
| | Detection of bcl-2 protein and bcl-2 messenger RNA in normal and neoplastic lymphoid tissues by immunohistochemistry and in situ hybridization | Q67903593 |
| | BER-H2: a new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope | Q69102794 |
| | Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease | Q69328485 |
| | Hodgkin's disease | Q70544607 |
| | Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes) | Q72722889 |
| | Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease | Q24324634 |
| | Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures | Q26778382 |
| | Report of the Committee on Hodgkin's Disease Staging Classification | Q28250452 |
| | Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells | Q28294137 |
| | Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death | Q29620000 |
| | Apoptotic cell death induced by c-myc is inhibited by bcl-2. | Q34255589 |
| | Bcl-2 initiates a new category of oncogenes: regulators of cell death | Q35675178 |
| | Epstein-Barr virus and Hodgkin's disease. A correlative in situ hybridization and polymerase chain reaction study | Q35831567 |
| | Programmed cell death: apoptosis and oncogenesis. | Q36399233 |
| | Structural analyses of EBER1 and EBER2 ribonucleoprotein particles present in Epstein-Barr virus-infected cells. | Q36876228 |
| | Detection of Epstein-Barr virus genomes in Hodgkin's disease: relation to age | Q37138731 |
| | Localization of Epstein-Barr virus-encoded small RNAs by in situ hybridization | Q37409158 |
| | Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells | Q37521760 |
| | BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death | Q37572590 |
| | High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of Hodgkin's disease occurring in Peru | Q38322415 |
| | Determination of the growth fraction in non-Hodgkin's lymphomas by monoclonal antibody Ki-S5 directed against a formalin-resistant epitope of the Ki-67 antigen | Q38485729 |
| | Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death | Q41678654 |
| | Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation | Q41736955 |
| | Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis | Q42074715 |
| | Viral involvement in Hodgkin's disease: detection of clonal type A Epstein-Barr virus genomes in tumour samples | Q42372619 |
| | Tumor cell growth fraction in Hodgkin's disease | Q42738263 |
| | A new proliferation-associated nuclear antigen detectable in paraffin-embedded tissues by the monoclonal antibody Ki-S1 | Q42755140 |
| | Hodgkin's disease, lymphocyte predominance type, nodular--further evidence for a B cell derivation. L & H variants of Reed-Sternberg cells express L26, a pan B cell marker. | Q42767543 |
| | High incidence of Epstein-Barr virus genomes in Hodgkin's disease. | Q42773829 |
| | Frequent detection of Epstein-Barr virus DNA by the polymerase chain reaction in lymph node biopsies from patients with Hodgkin's disease without genomic evidence of B- or T-cell clonality | Q43806958 |
| | Subtypes of Epstein-Barr virus (EBV) in Hodgkin's disease: association between B-type EBV and immunocompromise | Q43981811 |
| | Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease | Q44983123 |
| | Two distinct antigen systems in human B lymphocytes: identification of cell surface and intracellular antigens using monoclonal antibodies | Q45017867 |
| | Prognosis of Hodgkin's disease is not influenced by Epstein-Barr virus latent membrane protein | Q45056568 |
| | Epstein-Barr virus and childhood Hodgkin's disease in Honduras and the United States. | Q45775808 |
| | Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis | Q45859903 |
| | Epstein-Barr virus burden in Hodgkin's disease is related to latent membrane protein gene expression but not to active viral replication. | Q45872322 |
| | Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues | Q45875359 |
| | Influence of Epstein-Barr virus genomes on patient survival in Hodgkin's disease | Q45877372 |
| P433 | issue | 2 | |
| P304 | page(s) | 61-66 | |
| P577 | publication date | 1994-02-01 | |
| P1433 | published in | Annals of Hematology | Q15766509 |
| P1476 | title | The impact of EBV, proliferation rate, and Bcl-2 expression in Hodgkin's disease in childhood | |
| P478 | volume | 68 | |